Another Remdesivir lawsuit – maybe it’s time for a class action suit against the HHS and its alphabet soup of NIH/NIAID/CDC/FDA plus of course the WHO?
No updates on the case under the subscription request:
Criminal Prosecutions begin for Remdesivir treatments causing death (substack.com)
Maybe it has been settled out of court and is subject to a Non-Disclosure Agreement or still locked up in the court system?
One can’t help but wonder about the equivalency of Alex Jones losing a 1.44 billion dollar law-suit for his choice of words and the actual deaths of, potentially, 100’s of thousands from a known killer treatment protocol forced by regulators.
What's next for Alex Jones? What's his net worth? What to know (usatoday.com)
From here:
Referencing this tweet:
John Beaudoin is calling for a criminal investigation into remdesivir, citing data that it may have killed 100,000 people in the U.S.
For Massachusetts alone he compiled this chart:
The data in the chart is to 30 November each calendar year.
Which works out at an 11 month average of 1,154 acute renal failure deaths over 2015-2019 and an 11 month average of 1,854 for 2020-2022 – an increase of over 60% between the two periods.
If the extra deaths all show a correlation of C19 cases with injections of Remdesivir used, there is a strong case for causation.
I am not sure whether autopsies are possible, but those murdering patients will claim that “correlation does not equal causation” – but, in this and cases nationally it looks like it does.
From the CHD article:
“On Twitter, John Beaudoin is calling for a criminal investigation into the drug, citing data that it may have killed 100,000 people in the U.S.”
My guesstimate is that it could be at least double that number, all officially recorded as C19 deaths instead.
“Not to mention, remdesivir costs between $2,340 and $3,120, while the average treatment cost for ivermectin is $58. Do you think this has anything to do with remdesivir’s promotion and ivermectin’s vilification?
While WHO updated its guidance in April 2022 to recommend the use of remdesivir in “mild or moderate COVID-19 patients who are at high risk of hospitalization,” a study published in The Lancet found “no clinical benefit” from the use of remdesivir in hospitalized patients. Further, the investigators believed three deaths during the study were related to remdesivir.”
CHD references this Lancet article:
There is also this one about the use of Remdesivir in the Congo in the NEJM in 2019
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics | NEJM
And this earlier Lancet article from April 2020:
Lots more in the CHD article, including this:
“In late April 2022, the FDA even approved remdesivir as the first and only COVID-19 treatment for children under 12, including babies as young as 28 days, an approval that boggles the mind, considering COVID-19 is rarely serious in children while remdesivir is ineffective and carries a risk of serious, and deadly, side effects.
What’s worse, the drug is also approved for outpatient use in children, which is a first. Dr. Meryl Nass expressed her concerns about the FDA’s approval of remdesivir for outpatient use in babies, stating:
“The FDA just licensed Remdesivir for children as young as one month old. Both hospitalized children and outpatients may receive it. The drug might work in outpatients, but the vast majority of children have a very low risk of dying from COVID. If 7 deaths per 1,000 result from the drug, as … European investigators thought … it is possible it will harm or kill more children than it saves.”
Onwards!
Please subscribe, or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan
Amazing part is they knew this med was deadly from previous studies. Sue them!
Remdesivir was created by those evil doers at the University of North Carolina Chapel Hill.
The same people who with worked with the Bat Lady in Wuhan to weaponize the coronavirus to make it more transmissible and deadly.
Yep, those folks.
https://sph.unc.edu/sph-news/remdesivir-developed-at-unc-chapel-hill-proves-effective-against-covid-19-in-niaid-human-clinical-trials/